Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1966 5
1967 2
1968 2
1969 4
1970 2
1971 1
1972 1
1973 2
1974 4
1976 10
1977 4
1978 5
1979 5
1980 7
1981 8
1982 6
1983 6
1984 13
1985 7
1986 17
1987 13
1988 25
1989 25
1990 24
1991 35
1992 45
1993 48
1994 64
1995 50
1996 63
1997 86
1998 100
1999 136
2000 193
2001 201
2002 233
2003 299
2004 315
2005 387
2006 428
2007 456
2008 532
2009 634
2010 760
2011 869
2012 955
2013 1088
2014 1065
2015 1125
2016 1170
2017 1212
2018 1223
2019 1260
2020 1375
2021 1481
2022 1337
2023 1215
2024 1248
2025 1284
2026 676

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,197 results

Results by year

Filters applied: . Clear all
Page 1
Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease.
Lee YJ, Lee SJ, Kim JW, Lee SH, Kim GS, Park JH, Cho JM, Kang WC, Yoon HJ, Kim WH, Lee SJ, Lee JB, Jang JY, Shin S, Park IH, Kwon SU, Kim S, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, Kim BK; Ez-PAVE Investigators. Lee YJ, et al. Among authors: kim wh. N Engl J Med. 2026 Apr 9;394(14):1365-1375. doi: 10.1056/NEJMoa2600283. Epub 2026 Mar 28. N Engl J Med. 2026. PMID: 41910315 Clinical Trial.
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.
Choi KH, Kang D, Kim W, Doh JH, Kim J, Park YH, Ahn SG, Park JP, Kim SM, Cho BR, Nam CW, Cho JH, Joo SJ, Suh J, Jeong JO, Jang WJ, Goh CW, Yoon CH, Hwang JY, Lim SH, Lee SR, Shin ES, Kim BJ, Yu CW, Her SH, Kim HK, Park KT, Kim J, Kim J, Park TK, Lee JM, Cho J, Yang JH, Song YB, Choi SH, Gwon HC, Guallar E, Hahn JY; SMART-DECISION Investigators. Choi KH, et al. Among authors: kim w. N Engl J Med. 2026 Apr 2;394(13):1302-1312. doi: 10.1056/NEJMoa2601005. Epub 2026 Mar 30. N Engl J Med. 2026. PMID: 41910427 Clinical Trial.
Metabolic dysfunction and alcohol-associated liver disease (MetALD).
Gao B, Arab JP, Liangpunsakul S, Ding WX, Szabo G, Mehal W, Wang H, He Y, Stärkel P, Llorente C, Schnabl B, Hwang S, Vandermerwe S, Gao Y, Zheng MH, Kim W, George J, Bataller R, Loomba R, Leggio L, Tacke F. Gao B, et al. Among authors: kim w. eGastroenterology. 2025 Dec 25;3(4):e100319. doi: 10.1136/egastro-2025-100319. eCollection 2025. eGastroenterology. 2025. PMID: 41459093 Free PMC article. Review.
Agentic AI in Radiology.
Tripathi S, Cook TS, Kim W. Tripathi S, et al. Among authors: kim w. Radiology. 2026 Feb;318(2):e252730. doi: 10.1148/radiol.252730. Radiology. 2026. PMID: 41631988 No abstract available.
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial.
Karimi YH, Cheah CY, Clausen MR, Cunningham D, Farooq U, Feldman T, Ghesquieres H, Jurczak W, Linton KM, Phillips T, Vose JM, Kim WS, Jafarinasabian P, D'Angelo Månsson B, Soong D, Steele AJ, Li Z, Eskelund CW, Hutchings M, Thieblemont C. Karimi YH, et al. Among authors: kim ws. Ann Hematol. 2026 Feb 4;105(3):79. doi: 10.1007/s00277-026-06798-4. Ann Hematol. 2026. PMID: 41634395 Free PMC article.
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement.
Wu CT, Targher G, Byrne CD, Younossi ZM, Armstrong MJ, Luu HN, Lesmana CRA, Rustgi VK, Thomas JA, Okabayashi K, Lee JWJ, El-Serag HB, Kim W, Zhang HJ, Lonardo A, Souza M, George ES, Yang W, Yilmaz Y, Papatheodoridis G, Sookoian S, Romero-Gómez M, Sebastiani G, Schattenberg JM, El-Kassas M, Chan WK, Ocama P, Lupșor-Platon M, Perera N, Alswat K, Méndez-Sánchez N, Wong VW, Chai J, Tilg H, Sung JJ, Zheng MH. Wu CT, et al. Among authors: kim w. Gut. 2026 Jan 21:gutjnl-2025-337374. doi: 10.1136/gutjnl-2025-337374. Online ahead of print. Gut. 2026. PMID: 41770836
Brain structural abnormalities in treatment-resistant schizophrenia.
Etyemez S, Sivananthan R, Faria AV, Iasevoli F, Pontillo G, Di Giorgio A, Chung YC, Kim WS, Odkhuu S, Kwon JS, Kim M, Ha M, Georgiadis F, Milano BA, Kirschner M, Kaiser S, Tordesillas-Gutiérrez D, Sim K, Tan Y, Chan SKW, Turner JA, van Erp TGM, Lee J, Calhoun VD, Sawa A, Yang K. Etyemez S, et al. Among authors: kim ws. Mol Psychiatry. 2026 Mar 28. doi: 10.1038/s41380-026-03558-8. Online ahead of print. Mol Psychiatry. 2026. PMID: 41904268
21,197 results
You have reached the last available page of results. Please see the User Guide for more information.